COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
To improve care delivery, conserve personal protective equipment and limit the exposure to SARS-CoV-2, nurses at Montefiore Medical Center in New York City relocated smart IV infusion pumps outside of patient rooms
The Food and Drug Administration (FDA) warned people to stop using two tests produced by Empowered Diagnostics: CovClear COVID-19 Rapid Antigen Test
On Jan. 13, the Supreme Court of the United States (SCOTUS) issued its ruling on a challenge to the Centers for Medicare and Medicaid Services (CMS) requirement that health care facilities accepting CMS payment vaccinate their employees against COVID-19.
The American Hospital Association (AHA) this week urged the Centers for Medicare & Medicaid Services (CMS) to be flexible as it begins enforcing its COVID-19 vaccine mandate for hospitals
Changes to guidance from the Centers for Disease Control and Prevention (CDC) have left nurses who test positive for COVID-19 questioning how best to protect their patients.
A new page on the Food and Drug Administration (FDA) website explains how genetic mutations in the COIVID-19 virus may impact the accuracy of existing tests for SARS-CoV-2.
In line with recent court rulings, on Dec. 2 the Centers for Medicare and Medicaid Services (CMS) paused enforcement of its rule
The Centers for Disease Control and Prevention (CDC) updated its list of high-risk conditions for
Operational planning information for pediatric COVID-19 vaccination is now available on the website
Last week, the Biden-Harris Administration announced $2.1 billion in American Rescue Plan funding will be used to improve infection prevention and control activities across